LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi Arabia.

    Alandijany, Thamir A / El-Kafrawy, Sherif A / Al-Ghamdi, Abrar A / Qashqari, Fadi S / Faizo, Arwa A / Tolah, Ahmed M / Hassan, Ahmed M / Sohrab, Sayed S / Hindawi, Salwa I / Badawi, Maha A / Azhar, Esam I

    Healthcare (Basel, Switzerland)

    2021  Volume 9, Issue 1

    Abstract: ... coronavirus 2 (SARS-CoV-2) among blood donors during COVID-19 lockdown period. This study supports ... In response to the coronavirus disease 2019 (COVID-19), Saudi Arabia have imposed timely ... located in the western region of Saudi Arabia from 1 January to 31 May 2020. The study period covered two ...

    Abstract In response to the coronavirus disease 2019 (COVID-19), Saudi Arabia have imposed timely restrictions to minimize the infection spread, lower the risk for vulnerable groups, and reduce the pressure on healthcare services. The effectiveness of these measures has not been assessed comprehensively and, thereby, remains uncertain. Besides monitoring the number of COVID-19 cases diagnosed by molecular assays, the seroprevalence can serve as an indicator for the incidence rate among the general population. This study aimed to evaluate seroprevalence status of all healthy blood donors who attended one of the main largest hospital located in the western region of Saudi Arabia from 1 January to 31 May 2020. The study period covered two months prior to reporting the first COVID-19 case in the country on 2 March 2020. Importantly, it covered the period when "lock-down type" measures have been enforced. Samples were subjected to in-house enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and microneutralization (MN). The sero statuses of all samples were confirmed negative, demonstrating the lack of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among blood donors during COVID-19 lockdown period. This study supports the hypothesis that COVID-19 restrictions have potential for limiting the extent of the infection.
    Language English
    Publishing date 2021-01-05
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2721009-1
    ISSN 2227-9032
    ISSN 2227-9032
    DOI 10.3390/healthcare9010051
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown

    Thamir A. Alandijany / Sherif A. El-Kafrawy / Abrar A. Al-Ghamdi / Fadi S. Qashqari / Arwa A. Faizo / Ahmed M. Tolah / Ahmed M. Hassan / Sayed S. Sohrab / Salwa I. Hindawi / Maha A. Badawi / Esam I. Azhar

    Healthcare, Vol 9, Iss 51, p

    A Study from Saudi Arabia

    2021  Volume 51

    Abstract: ... coronavirus 2 (SARS-CoV-2) among blood donors during COVID-19 lockdown period. This study supports ... In response to the coronavirus disease 2019 (COVID-19), Saudi Arabia have imposed timely ... located in the western region of Saudi Arabia from 1 January to 31 May 2020. The study period covered two ...

    Abstract In response to the coronavirus disease 2019 (COVID-19), Saudi Arabia have imposed timely restrictions to minimize the infection spread, lower the risk for vulnerable groups, and reduce the pressure on healthcare services. The effectiveness of these measures has not been assessed comprehensively and, thereby, remains uncertain. Besides monitoring the number of COVID-19 cases diagnosed by molecular assays, the seroprevalence can serve as an indicator for the incidence rate among the general population. This study aimed to evaluate seroprevalence status of all healthy blood donors who attended one of the main largest hospital located in the western region of Saudi Arabia from 1 January to 31 May 2020. The study period covered two months prior to reporting the first COVID-19 case in the country on 2 March 2020. Importantly, it covered the period when “lock-down type” measures have been enforced. Samples were subjected to in-house enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and microneutralization (MN). The sero statuses of all samples were confirmed negative, demonstrating the lack of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among blood donors during COVID-19 lockdown period. This study supports the hypothesis that COVID-19 restrictions have potential for limiting the extent of the infection.
    Keywords COVID-19 ; SARS-CoV-2 ; Saudi Arabia ; blood donors ; seroprevalence ; ELISA ; Medicine ; R
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top